中国药物警戒 ›› 2012, Vol. 9 ›› Issue (10): 628-630.

• 综述 • 上一篇    下一篇

高渗药物使用风险与规避

崔向丽1, 隋大立2, 李靖2, 张宇2, 史卫忠1, 赵志刚1*   

  1. 1 首都医科大学附属北京天坛医院药剂科,北京 100050；
    2 首都医科大学附属北京天坛医院神经外科,北京 100050
  • 收稿日期:2012-05-02 出版日期:2012-10-10 发布日期:2015-08-07
  • 通讯作者: 赵志刚,男,硕士,主任药师,医院药学。E-mail:1022zzg@sina.com
  • 作者简介:崔向丽,女,博士,主管药师,神经外科合理用药。

Risk and Avoidance of Hypertonic Drug Use

CUI Xiang-li1, SUI Da-li2, LI Jing2, ZHANG Yu2, SHI Wei-zhong1, ZHAO Zhi-gang1*   

  1. 1 Department of Pharmacy, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China;
    2Department of Neurosurgery, Beijing Tiantan Hospital, Capital Medical University, Beijing 100050, China
  • Received:2012-05-02 Online:2012-10-10 Published:2015-08-07

PDF (PC)

205

摘要： 高渗药物目前临床应用广泛,种类多,包括脱水药、电解质、高渗糖、扩容剂、造影剂等,快速滴注容易引起静脉炎。高渗造影剂还可引起肾功能损害,本文对高渗药物的分类和用药风险进行汇总,并总结了高渗药物静脉炎的防治方法,提示临床医护人员使用高渗药物应警惕其使用风险并掌握处理办法。

关键词: 高渗药物, 风险, 静脉炎, 治疗

Abstract: Hypertonic drugs are widely used in clinical medication, including many kinds, such as dehydration drug, electrolyte, hypertonic sugar, expansion agent and contrast agent. Rapid infusion of these drugs easily leads to phlebitis. Hypertonic contrast agents can also cause kidney damage. The classification and risk of hypertonic drugs were summarized in this article, and the prophylaxis and treatment of phlebitis induced by these drugs were also summarized. Our aim is to suggest that clinical staff should be alert to the risk while they use hypertonic drugs.

Key words: hypertonic drugs, risk, phlebitis, therapy